← All episodes

Joe Rogan Experience #2469 - Brigham Buhler

| 13 products mentioned
Watch on YouTube peptides fda regulation pharmaceutical lobbying testosterone replacement therapy preventative medicine glp-1 weight loss drugs compounding pharmacies

Brigham Buhler discusses the regulatory battle over peptides and the systemic failures of the FDA and pharmaceutical industry in preventing chronic disease. Buhler explains how peptides were arbitrarily banned without safety evidence, how big pharma's lobbying power shapes policy, and why a shift toward preventative and personalized medicine is essential for American health—while also detailing the current "wild west" black market that has emerged as a result of these restrictions.

Key takeaways
  • The fear of testosterone replacement therapy causing prostate cancer stems from a flawed 1930s study with only three subjects, one of whom was chemically castrated, yet this myth persists in medical dogma a century later.
  • GLP-1 peptides are being lobbied against by pharmaceutical companies despite being worth billions in blockbuster revenue, with big pharma falsely claiming losses while their market values have 7xed in recent years.
  • The current regulatory environment has forced 80% of peptide prescriptions into unregulated black and gray markets, making it more dangerous than legal, clinician-supervised compounding would be.
  • The FDA approval process costs $1-3 billion and is designed around big pharma's monopoly model, making it impossible for affordable preventative treatments like naturally-occurring peptides to reach patients legally.
  • Compounding pharmacies that follow strict safety protocols—including third-party verification, FDA-approved ingredient suppliers, and regular state/federal inspections—offer a viable alternative to both big pharma and black market suppliers.
  • Preventative medicine powered by diagnostic testing (blood work, DEXA scans, VO2 max tests, genetic sequencing) combined with AI can identify disease years before symptoms appear, but insurance-based models actively discourage this approach.
  • States like Texas, Florida, and Arizona are moving faster than the federal government by passing "right to try" laws that allow patients sovereignty over their health decisions for conditions like Parkinson's, creating a model that could expand nationally.

Recommendations (9)

colostrum uses

"One thing that does help is colostrum. I take colostrum. Yeah. Makes a big difference. If you take it a lot, take it every day. Stay consistent."

Brigham Buhler · ▶ 1:12

"We have plasma pheresis here in Austin, Texas. We use it. We added it to the clinic 3 months ago. Think of it like an oil change for your body."

Brigham Buhler · ▶ 2:14:21

"We did a microplastics test and he had the most freaking microplastics that we've ever seen."

Brigham Buhler · ▶ 2:17:57

"We're tracking you via V2 max. We're tracking you via wearables. All of that vertically integrated in real time."

Brigham Buhler · ▶ 1:33:36

DEHEXA uses

"I've taken things like DEHEXA, for me personally, it 100% improved my neurocognitive function. It 100% improved my data recall and retention."

Brigham Buhler · ▶ 1:22:23

"Less than one in 1,000 people have ever had their genome sequenced. We're taking all of the knowledge that Ryan and these geneticists have and we're trying to automate it using large language model..."

Brigham Buhler · ▶ 1:27:22

"This is the stem cell answer that has eluded scientists for decades. These cells will literally go into the body and take on the phenotype of any damaged cell."

Brigham Buhler · ▶ 1:50:00

DEXA scans uses

"You can't lie on a DEXA. That's a real analysis of your visceral fat, your subcutaneous fat, how much fat's packed around your organs."

Brigham Buhler · ▶ 1:35:32

Blind Spots recommends

"I don't know if have you ever read his book? It's called Blind Spot. One of the things that I love is I philosophically agree with everything that Marty laid out."

Brigham Buhler · ▶ 4:53

Mentioned (4)

BPC-157 "A lot of times there's a reason why like BPC-157 there's a patent out of Croatia I believe on tha..." ▶ 30:32
Retatrutide "Retatrutide is a triple agonist being developed by Eli Lilly. It hits three different receptor si..." ▶ 1:03:23
ChatGPT
ChatGPT "These companies have avoided all of that and people were using things like ChatGPT. But now ChatG..." ▶ 1:05:35
CJC ipamorelin "Like CJC ipamorelin, you could feel it when you take it. I know people that have bought stuff onl..." ▶ 58:08